Breakthrough in Management of Cardiovascular Diseases by Artificial Intelligence in Healthcare Settings-Reference-Cited by-同舟云学术

Breakthrough in Management of Cardiovascular Diseases by Artificial Intelligence in Healthcare Settings

Published:2023-05-09 Issue: Volume: Page:177-193
ISSN:
Container-title:Machine Intelligence for Internet of Medical Things: Applications and Future Trends
language:
Short-container-title:

Author:

Narasimha Gunturu Lakshmi¹,Dornadula Girirajasekhar²,Naveen Nimbagal Raghavendra³

Affiliation:

1. Scientimed Solutions Private Limited,Mumbai,India,

2. Annamacharya College of Pharmacy,Department of Pharmacy Practice,Rajampeta,India,

3. Adichunchanagiri University,Department of Pharmaceutics,Adichunchanagiri,India,571418,

Abstract

The cardiovascular system includes the heart and its associated blood vessels. Disorders of this cardiac system are called Cardiovascular disorders (CVD). Management of CVDs is often complex due to challenges like inadequate patient care, readmissions, low cost-effectiveness, and cost reductions in preventions, treatments, and lifestyle modifications. Hence, to overcome these challenges, Artificial Intelligence (AI) is being developed. They addressed emerging problems in clinical and health care settings and had a tremendous impact on the public. Implementation of AI in cardiovascular medicine affects more on new findings. It also provides a high level of supporting evidence that may be useful within the evidence-based research paradigm. A review of available free full-text literature in the PubMed database was carried out to study the influence of AI on health care settings. This work reviews AI-based algorithms used in cardiac practice and the applications of AI in cardiovascular medicine in terms of interpretation of results and medical image analysis. <br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference38 articles.

1. Mondal B.; Artificial intelligence: state of the art,” in Intelligent Systems. Ref Libr 2019,172,389-425

2. Virani S.S.; Alonso A.; Benjamin E.J.; Bittencourt M.S.; Callaway C.W.; Carson A.P.; Chamberlain A.M.; Chang A.R.; Cheng S.; Delling F.N.; Djousse L.; Elkind M.S.V.; Ferguson J.F.; Fornage M.; Khan S.S.; Kissela B.M.; Knutson K.L.; Kwan T.W.; Lackland D.T.; Lewis T.T.; Lichtman J.H.; Longenecker C.T.; Loop M.S.; Lutsey P.L.; Martin S.S.; Matsushita K.; Moran A.E.; Mussolino M.E.; Perak A.M.; Rosamond W.D.; Roth G.A.; Sampson U.K.A.; Satou G.M.; Schroeder E.B.; Shah S.H.; Shay C.M.; Spartano N.L.; Stokes A.; Tirschwell D.L.; VanWagner L.B.; Tsao C.W.; Heart disease and stroke statistics—2020 update: A report from the American Heart Association. Circulation 2020,141(9),e139-e596

3. Johnson K.W.; Torres Soto J.; Glicksberg B.S.; Shameer K.; Miotto R.; Ali M.; Ashley E.; Dudley J.T.; Artificial Intelligence in Cardiology. J Am Coll Cardiol 2018,71(23),2668-2679

4. Hodos R.A.; Kidd B.A.; Shameer K.; Readhead B.P.; Dudley J.T.; Wiley Interdiscip Rev Syst Biol Med In silico methods for drug repurposing and pharmacology.2016,8(3),186-210

5. H. El-Saadawy, M. Tantawi, H. A. Shedeed, and M. F. Tolba, “Electrocardiogram (ECG) heart disease diagnosis using PNN, SVM and Softmax regression classifiers,” in 2017 IEEE 8th International Conference on Intelligent Computing and Information Systems, pp. 106–110, 2017